Rapid molecular diagnostics for drug-resistant tuberculosis in India.


Rajeswari, R.; Muniyandi, M.


Expert Review of Anti-infective Therapy; 2018; 16(3): 197-204.  


Abstract: Introduction: Rapid molecular diagnostic methods help in the detection of TB and Rifampicin resistance. These methods detect TB early, are accurate and play a crucial role in reducing the burden of drug resistant tuberculosis.


Areas covered: This review analyses rapid molecular diagnostic tools used in the diagnosis of MDR-TB in India, such as the Line Probe Assay and GeneXpert. We have discussed the burden of MDR-TB and the impact of recent diagnostic tools on case detection and treatment outcomes. This review also discusses the costs involved in establishing these new techniques in India.


Expert commentary: Molecular methods have considerable advantages for the programmatic management of drug resistant TB. These include speed, standardization of testing, potentially high throughput and reduced laboratory biosafety requirements. There is a desperate need for India to adopt modern, rapid, molecular tools with point-of-care tests being currently evaluated. New molecular diagnostic tests appear to be cost effective and also help in detecting missing cases. There is enough evidence to support the scaling up of these new tools in India.


Keywords: MDR-TB; Rapid molecular diagnostics tools; LPA; Xpert MTB/RIF; Cost; Point of care test; India



Back to List of publications / Home